Please login to the form below

Not currently logged in
Email:
Password:

Dova Pharmaceuticals

This page shows the latest Dova Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Shionogi launches thrombocytopenia treatment Mulpleo in the UK

Shionogi launches thrombocytopenia treatment Mulpleo in the UK

Earlier this month, NICE also published final draft guidance recommending the use of Dova Pharmaceuticals’ Doptelet (avatrombopag) for thrombocytopenia who are scheduled to undergo an invasive procedure.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    He brings 18 years of commercial experience in the biotechnology sector to the role, most recently serving as chief commercial officer at Dova Pharmaceuticals. ... He has also held sales, marketing and medical affairs leadership roles at Sarepta

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....